Bringing It All Together
Welcome and introduction to the clinic This could be a one-pager that welcomes the patient to the clinic, provides an explanation of the philosophy of the clinic and the modalities…
ONCOLOGY
The Power of Movement: Integrating Exercise
• A study of women with non-metastatic colorectal cancer (Nurses’ Health Study Cohort) found that higher levels of exercise after diagnosis was significantly associated with reduced cancer-specific death and overall…
Imaging Characteristics of Normal Liver and Liver Tumors
Ultrasound CT MRI Angiography – Hepatomegaly (early) – Irregular contour – Right lobe and medial left lobe atrophy; lateral left lobe and caudate lobe enlargement – Coarsened echotexture – Arteriovenous…
Surgical Considerations
Primary liver tumors Hepatocellular carcinoma Cholangiocarcinoma Hilar cholangiocarcinoma Gallbladder cancer Metastatic liver disease Colorectal cancer Neuroendocrine tumors Non-colorectal non-neuroendocrine tumors The oncologic appropriateness of surgical resection varies according to the…
Liver Anatomy and Function
Fig. 1.1 Schematic picture of the segments of the liver. The liver can be divided into eight segments based on first and second order divisions of the hepatic artery, portal vein,…
Intrahepatic and Hilar Cholangiocarcinomas: Epidemiology, Basic Principles of Treatment, and Clinical Data
Fig. 15.1 Cholangiocarcinoma classification: a Intrahepatic cholangiocarcinoma: tumors in the bile ducts within the hepatic parenchyma b Extrahepatic cholangiocarcinoma: tumors from the junction of the left and right hepatic ducts to…
Hepatocellular Carcinoma: Epidemiology, Basic Principles of Treatment, and Clinical Data
Fig. 13.1 Geographic variation in liver cancer incidence (age-standardized). [Reproduced with permission from Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D,…
Radiation Therapy for Intrahepatic and Hilar Cholangiocarcinoma: Clinical Data
Author, year of publication Study design # of IHC pts Tumor size (cm3) Mode of RT delivery Total dose (Gy) # Fx One-year LC One-year OS Toxicity Liu et al….
Radiation Therapy for Liver Metastases: Clinical Data
Author; year Design Pts with liver metastases Frx × dose m-FU mts Local control 2-years (%) Survival 1-, 2-years (%) Severe morbidity Schefter 2005 [19] Phase I 18 3 × 12–20 Gy NR NR NR…
